Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PIRS

Pieris Pharmaceuticals (PIRS) Stock Price, News & Analysis

Pieris Pharmaceuticals logo

About Pieris Pharmaceuticals Stock (NASDAQ:PIRS)

Advanced Chart

Key Stats

Today's Range
$13.26
$15.35
50-Day Range
$13.60
$17.07
52-Week Range
$6.20
$18.68
Volume
51,728 shs
Average Volume
86,643 shs
Market Capitalization
$17.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PIRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pieris Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PIRS Stock News Headlines

Pieris Pharmaceuticals Inc
Palvella Therapeutics Inc (PVLA)
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
One new option listing and one option delisting on December 16th
See More Headlines

PIRS Stock Analysis - Frequently Asked Questions

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) announced its quarterly earnings data on Tuesday, November, 2nd. The biotechnology company reported ($19.20) EPS for the quarter, hitting analysts' consensus estimates of ($19.20). The biotechnology company earned $4.06 million during the quarter, compared to analyst estimates of $7.98 million. Pieris Pharmaceuticals had a negative trailing twelve-month return on equity of 80.93% and a negative net margin of 39.71%.

Pieris Pharmaceuticals shares reverse split on the morning of Tuesday, April 23rd 2024.The 1-80 reverse split was announced on Tuesday, April 23rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pieris Pharmaceuticals investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CymaBay Therapeutics (CBAY), Adobe (ADBE), GE Aerospace (GE) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
11/02/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PIRS
CIK
1583648
Employees
140
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($12.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$24.54 million
Net Margins
-39.71%
Pretax Margin
-1,179.96%
Return on Equity
-80.93%
Return on Assets
-59.55%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.82
Quick Ratio
4.82

Sales & Book Value

Annual Sales
$42.81 million
Price / Sales
0.42
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$21.66 per share
Price / Book
0.63

Miscellaneous

Outstanding Shares
1,320,000
Free Float
1,236,000
Market Cap
$17.95 million
Optionable
Optionable
Beta
0.61

Social Links

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:PIRS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners